Summary
RMC No. 129-2022 publishes the September 1, 2022 letter of the Food and Drug Administration (FDA) endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act).
CollapseExpand
Key points
- Update to the list. The update deletes certain medicines prescribed for mental illnesses from the List of VAT-Exempt Medicines.
- Source of the letter. The letter comes from FDA Director General Samuel A. Zacate.
Deadlines and effectivity
- Letter dated September 1, 2022
Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.
Copies of BIR issuances are hosted here for reference. For the official version, check bir.gov.ph. Summaries by Tax Resources PH are not a substitute for the full text or professional advice.
